Distinct metabolic preference of atypical KRAS mutant
- PMID: 33209906
- PMCID: PMC7661907
- DOI: 10.21037/atm-20-3252
Distinct metabolic preference of atypical KRAS mutant
Conflict of interest statement
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3252). The author has no conflicts of interest to declare.
Comment on
-
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.Cancer Discov. 2020 Jan;10(1):104-123. doi: 10.1158/2159-8290.CD-19-1006. Epub 2019 Oct 24. Cancer Discov. 2020. PMID: 31649109 Free PMC article.
References
-
- Hobbs GA, Baker NM, Miermont AM, et al. Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. Cancer Discov 2020;10:104-23. 10.1158/2159-8290.CD-19-1006 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous